FDA In Brief: FDA issues strategic roadmap for healthy innovation and safer families in 2018 and beyond
For Immediate Release: Jan. 11, 2017
"We’re at an inflection point in the state of science and medicine and for FDA, this presents new challenges and opportunities. Our science-based and patient-centered regulatory approach enables the agency to play a critical role in aligning science and policy to improve the health and welfare of Americans. The work we do now will define how society uses and benefits from many of the new and transformative technologies that we’re being asked to evaluate. Our 2018 Strategic Policy Roadmap outlines the approach we’ll take to both fulfill our public health mission and bolster the advances made by the agency this past year,” said FDA Commissioner Scott Gottlieb, M.D.
Today, FDA Commissioner Scott Gottlieb, M.D., presented agency staff with the FDA’s 2018 Strategic Policy Roadmap — a strategic vision for key public health initiatives and the agency’s plan to optimize resources to fulfill them.
The Roadmap focuses on four strategic policy areas: addiction crises, innovation, consumer empowerment and the FDA workforce. The Roadmap recognizes the important work already accomplished in many of these areas, but outlines critical next steps that must be undertaken to pursue these objectives and further improve public health.
In each of the four policy areas, specific policy efforts are highlighted along with a list of actions that will be undertaken to achieve the Roadmap’s goals. Some examples include new steps to support and streamline the development and approval of treatments that address addiction, reducing burdens for creating and approving generic drugs, and extending new hiring and pay authorities to help recruit and retain talented staff.
Follow our progress in meeting these public health priorities on social media with #FDARoadmap.
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.